Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02420717 |
Title | Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | M.D. Anderson Cancer Center |
Indications | |
Therapies |
Cyclophosphamide + Dexamethasone + Doxorubicin + Vincristine Sulfate Mercaptopurine + Methotrexate + Prednisone + Vincristine Sulfate |
Age Groups: | child | adult |
Covered Countries | USA |